 |
|
Incidence and risk factors of immune checkpoint inhibitor-induced colitis in Korean patients with cancer
Tae Kyun Kim, Hyun Seok Lee, Eun Soo Kim
Korean J Intern Med. 2025;40(1):49-56. Published online 2025 Jan 1 DOI: https://doi.org/10.3904/kjim.2024.135
|
|
Citations to this article as recorded by
 Who is at risk for immune checkpoint inhibitor-induced colitis among Korean patients?
Ji Hyun Kim, Sung Chul Park
The Korean Journal of Internal Medicine.2025; 40(1): 3. CrossRef Incidence of and Risk Factors for Anti-PD-1/PD-L1- Associated Diarrhea and Colitis: A Retrospective Cohort Study of the Chinese Population
Wei Chen, Yan Wang, Mengyu Zhao, Hong Zhang, Ye Zong, Xinyan Zhao
Medicina.2025; 61(2): 353. CrossRef Immune checkpoint inhibitors: From friend to foe
Prem Rajak
Toxicology Reports.2025; 14: 102033. CrossRef Ipilimumab/nivolumab/pembrolizumab
Reactions Weekly.2025; 2065(1): 174. CrossRef
|